Trial Outcomes & Findings for The Prevent Anal Cancer Palpation Study (NCT NCT04090060)

NCT ID: NCT04090060

Last Updated: 2024-07-09

Results Overview

This measure will record the number of concordant digital anal examination results. A concordant result means that the subject and clinician agree as to the presence or absence of an abnormality.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

718 participants

Primary outcome timeframe

Day 1

Results posted on

2024-07-09

Participant Flow

After consenting online, individuals must have attended a visit 1 where the intervention was delivered and followed by randomization into Practice or Control arms. The stated number of enrollees, 718, represents unique individuals who attended visit 1 and received the intervention regardless of the individual choosing to participate in the intervention as a single person or with a partner. The outcomes are assessed at the individual level and not couple level.

Participant milestones

Participant milestones
Measure
Practice Self-/Companion Exams
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 men and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results. Thus the Overall Number of Baseline Participants, Overall number of Participants Analyzed and Number of Participants at Risk reflect a unique number of participants and NOT a combination of participants and dyads.
Control Arm
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits. The Overall Number of Baseline Participants, Overall number of Participants Analyzed and Number of Participants at Risk reflect a unique number of participants and NOT a combination of participants and dyads.
Overall Study
STARTED
359
359
Overall Study
COMPLETED
283
282
Overall Study
NOT COMPLETED
76
77

Reasons for withdrawal

Reasons for withdrawal
Measure
Practice Self-/Companion Exams
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 men and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results. Thus the Overall Number of Baseline Participants, Overall number of Participants Analyzed and Number of Participants at Risk reflect a unique number of participants and NOT a combination of participants and dyads.
Control Arm
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits. The Overall Number of Baseline Participants, Overall number of Participants Analyzed and Number of Participants at Risk reflect a unique number of participants and NOT a combination of participants and dyads.
Overall Study
Lost to Follow-up
76
77

Baseline Characteristics

The Prevent Anal Cancer Palpation Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Practice Self-/Companion Exams
n=359 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 men and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=359 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Total
n=718 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
340 Participants
n=5 Participants
342 Participants
n=7 Participants
682 Participants
n=5 Participants
Age, Categorical
>=65 years
19 Participants
n=5 Participants
17 Participants
n=7 Participants
36 Participants
n=5 Participants
Sex/Gender, Customized
Male
337 Participants
n=5 Participants
338 Participants
n=7 Participants
675 Participants
n=5 Participants
Sex/Gender, Customized
Female
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Sex/Gender, Customized
Trans Man
3 Participants
n=5 Participants
6 Participants
n=7 Participants
9 Participants
n=5 Participants
Sex/Gender, Customized
Trans Woman
7 Participants
n=5 Participants
4 Participants
n=7 Participants
11 Participants
n=5 Participants
Sex/Gender, Customized
Non-Binary
10 Participants
n=5 Participants
8 Participants
n=7 Participants
18 Participants
n=5 Participants
Sex/Gender, Customized
Other
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Sex/Gender, Customized
Not Reported
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
92 Participants
n=5 Participants
72 Participants
n=7 Participants
164 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
266 Participants
n=5 Participants
286 Participants
n=7 Participants
552 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
9 Participants
n=5 Participants
4 Participants
n=7 Participants
13 Participants
n=5 Participants
Race (NIH/OMB)
Asian
11 Participants
n=5 Participants
22 Participants
n=7 Participants
33 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
88 Participants
n=5 Participants
93 Participants
n=7 Participants
181 Participants
n=5 Participants
Race (NIH/OMB)
White
217 Participants
n=5 Participants
212 Participants
n=7 Participants
429 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
30 Participants
n=5 Participants
20 Participants
n=7 Participants
50 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
n=5 Participants
7 Participants
n=7 Participants
11 Participants
n=5 Participants
Region of Enrollment
United States
359 participants
n=5 Participants
359 participants
n=7 Participants
718 participants
n=5 Participants

PRIMARY outcome

Timeframe: Day 1

Population: Of 718 individuals, outcome results were available for 714 individuals with two participants in the Practice Self/Companion Exams arm and two participants in the Control Arm not completing the self-/companion examination or not completing a digital anal rectal examination. Of the 714, 357 were in the practice arm and 357 in the control arm. Of the 714, 658 completed a self-exam and 56 completed a companion exam.

This measure will record the number of concordant digital anal examination results. A concordant result means that the subject and clinician agree as to the presence or absence of an abnormality.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=331 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=327 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Concordance Between Self-examination and Clinician Examination
234 Participants
247 Participants

PRIMARY outcome

Timeframe: Day 180.

Population: Seventy of 331 participants in the Practice Self-Companion Exams arm and 72 of 327 participants in the control arm completing a baseline examination (Outcome Measure 1) did not complete an examination at 180 days.

This measure will record the number of concordant digital anal examination results. A concordant result means that the subject and clinician agree as to the presence or absence of an abnormality.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=261 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=255 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Concordance Between Self-examination and Clinician Examination
248 Participants
246 Participants

PRIMARY outcome

Timeframe: Day 1

Population: The unit of analysis is the individual and not the couple.

This measure will record the number of concordant digital anal examination results. A concordant result means that the subject's companion and clinician agree as to the presence or absence of an abnormality.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=26 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=30 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Concordance Between Companion Examination and Clinician Examination
20 Participants
22 Participants

PRIMARY outcome

Timeframe: Day 180

Population: Twenty of twenty-six participants in the Practice Self-/Companion Exams arm and twenty-six of thirty participants in the Control Arm completed companion examinations at 180 days.

This measure will record the number of concordant digital anal examination results. A concordant result means that the subject's companion and clinician agree as to the presence or absence of an abnormality.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=20 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=26 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Concordance Between Companion Examination and Clinician Examination
19 Participants
23 Participants

PRIMARY outcome

Timeframe: Day 180

Population: All units of data are unique individuals and not couples.

This measure will count the number of subjects who practiced the self examination at least one time between days 1 and 180.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=331 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=327 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Number of Persons Who Practice the Self Examination
261 Participants
255 Participants

PRIMARY outcome

Timeframe: Day 180

Population: The unit of analysis is the individual not the dyad (or couple).

This measure will count the number of subjects who practiced the companion examination at least one time between days 1 and 180.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=26 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=30 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Number of Persons Who Practice the Companion Examination
20 Participants
26 Participants

SECONDARY outcome

Timeframe: Day 1

Population: This measure involves only the participants living in either the Chicago or Houston metropolitan areas.

This measure will count the number of subjects in outcome measures 1, 2, 5 and 9 comparing subjects living in the Chicago and Houston metropolitan areas.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=331 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=327 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Measuring the Difference Between Chicago and Houston Self-exam Concordance.
Chicago
127 Participants
139 Participants
Measuring the Difference Between Chicago and Houston Self-exam Concordance.
Houston
107 Participants
108 Participants

SECONDARY outcome

Timeframe: Day 1

Population: This measure involves only the participants living in either the Chicago or Houston metropolitan areas who conducted companion examinations.

This measure will count the number of subjects in outcome measures 3, 4, 6 and 9 comparing companions living in the Chicago and Houston metropolitan areas.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=26 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=30 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Measuring the Difference Between Chicago and Houston Companion Exam Concordance.
Chicago
10 Participants
6 Participants
Measuring the Difference Between Chicago and Houston Companion Exam Concordance.
Houston
10 Participants
16 Participants

SECONDARY outcome

Timeframe: Day 1

Population: Waist circumference was not measured for 2 individuals in the practice arm and 2 individuals in the control arm.

This measure will record subject waist circumference in cm.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=329 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=325 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Waist Circumference for Persons Doing Self-examinations
96.1 centimeter
Interval 66.0 to 171.2
95.3 centimeter
Interval 66.6 to 178.0

SECONDARY outcome

Timeframe: Day 1

Population: This measure involves only the participants who performed a self-examination and whose waste circumference was measured. Two participants in each arm were missing waist circumference.

This measure will record the number of concordant digital anal examination results in persons with less than or equal to 102 cm waist size versus greater than 102 cm waist size. A concordant result means that the subject and clinician agree as to the presence or absence of an abnormality.

Outcome measures

Outcome measures
Measure
Practice Self-/Companion Exams
n=329 Participants
300 individuals and 50 couples will be randomized to practice arm. Practice Self-/Companion Exams: 300 individuals and 50 couples will be randomized and encouraged to practice anal exams at home before Visit 2. Practice results will be elicited by staff. They will return for Visit 2 (six months after Visit 1). At Visit 2, they will complete a pre- and post-visit computer assisted self-interview. They will receive written instructions. After completing an anal self-exam or anal companion exam at home, they will record the results. At the clinic, they will have a Digital Anal Rectal Exam (DARE) by a clinician who will give the subject his results.
Control Arm
n=325 Participants
300 individuals and 50 couples will neither be encouraged nor discouraged to practice self-/companion exam. Control Arm: 300 individuals and 50 couples will be randomized to this arm. Following Visit 1, they will neither be encouraged nor discouraged from practicing self- or companion exam. They will return for Visit 2 (six months after Visit 1). They will receive written anal exam instructions. They will then complete the self- or companion exam at home, and record the results. At the clinic, they will receive a clinician DARE. Clinicians will give DARE results. Persons will take a post-exam computer-assisted self-interview. Persons in this arm (control) will be asked if they have performed exams between visits.
Concordance Between Self-examination and Clinician Examination Stratified by Waist Circumference.
Circumference >102 cm
79 Participants
71 Participants
Concordance Between Self-examination and Clinician Examination Stratified by Waist Circumference.
Circumference <= 102 cm
153 Participants
174 Participants

Adverse Events

Practice Self-/Companion Exams

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Arm

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Alan Nyitray, PhD

Medical college of Wisconsin

Phone: 414-955-7701

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place